Moderna reports first quarterly profit but faces market pressure over patents

  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

South Africa News News

Drugmaker revenues of $1.94bn were below Wall Street’s expectations

Moderna fell in trading on Thursday after its vaccine revenues missed analysts’ expectations and the company made a small increase in product sales projections for the year.

While Moderna recorded its first profitable quarter, revenues of $1.94bn came in below Wall Street expectations. The 4.3% increase in projected annual product sales to $19.2bn pales in comparison to the $26bn that rival Pfizer now expects from Covid vaccine sales this year.

The final count depends on the mix of primary two-dose vaccine and booster shots that use less vaccine material.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines